FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)

View source ↗

Summary

The FDA approved a supplemental application for ramipril (generic ramipril) filed by Chartwell RX, LLC., under ANDA 078745.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Failure
• Hypertension
• Myocardial Infarction
• Stroke

Drugs mentioned

• Ramipril (ramipril)

Snippet

SUPPL AP for RAMIPRIL (RAMIPRIL)